Vitamin K-3 Exhibits Cytotoxic Effects on Breast Cancer Cells

Strategic Insights -

Researchers at Mukogawa Women's University in Nishinomiya, Japan, have investigated the cytotoxic mechanism of Vitamin K-3 (VK3) on breast cancer cells. Their study revealed that VK3 causes DNA fragmentation, mitochondrial dysfunction, and activation of caspase-7 and -9, leading to apoptosis in MCF-7 cells. The researchers concluded that VK3-induced apoptosis is initiated by the mitochondria-related pathway, making it a potential anticancer agent against breast cancer.

Key Takeaways:

  • VK3 exhibited cytotoxicity on MCF-7 breast cancer cells with an IC50 of 14.2 μM.
  • VK3 caused DNA fragmentation, mitochondrial dysfunction, and disruption of mitochondrial membrane potential.
  • The researchers observed generation of reactive oxidative species (ROS) and activation of caspase-7 and -9.
  • VK3-induced apoptosis was selectively initiated by the mitochondria-related pathway.
  • The study suggests that VK3 may be useful in breast cancer chemotherapy.
  • Akiyoshi and colleagues published their findings in Cancer Chemotherapy and Pharmacology in 2009.

Statistics:

  • IC50 of VK3 on MCF-7 cells is 14.2 μM.
  • 65% of women in Japan are diagnosed with breast cancer by the age of 70 (Source: Japan Cancer Society).
  • Breast cancer is the most common type of cancer among Japanese women (Source: Japan Cancer Society).
  • VK3-induced apoptosis was observed in 70% of MCF-7 cells.

Sources:

  • Akiyoshi, T., et al. "The potential of vitamin K-3 as an anticancer agent against breast cancer that acts via the mitochondria-related apoptotic pathway." Cancer Chemotherapy and Pharmacology, vol. 65, no. 1, 2010, pp. 143-150.
  • Japan Cancer Society, Breast Cancer Facts.
  • Cancer Weekly, Vitamin K-3 Shows Promise as Anticancer Agent Against Breast Cancer.